Hyundai Bioland

Hyundai Bioland is a company listed under the stock ticker 052260 (KR).

View the org chart displaying its 4 main executives

Most searched biographies at Hyundai Bioland

• Chan Bok Jung, Chief Executive Officer
• Taek Seon Lee, Director
• Gwang Hyeon Goh, Non-Executive Independent Director

Create your alert
to follow the executive moves at Hyundai Bioland.

Hyundai Bioland has 2,288 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Hyundai Bioland

Social media about Hyundai Bioland

• Hyundai Bioland on Wikipedia, Google News & Yahoo Finance
• Hyundai Bioland on LinkedIn, Twitter & YouTube

Contact by email its executives including Chan Bok Jung

Call Hyundai Bioland at +82 41...

View the org chart

Register to receive your alert

Report an error